Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Meda Pharmaceuticals and Cipla sue Apotex to enforce Dymista patents
Meda holds the NDA to manufacture and market Dymista in the US for the treatment of seasonal allergic rhinitis
Stelis Biopharma commences construction of Malaysia plant
Strides Arcolab's arm has entered into a build and lease agreement with Bio-XCell for the construction of 1,40,000 sq feet…
Suven Life Sciences raises Rs 200 crore through QIP
The company accordingly will issue 1,04,53,690 equity shares of face value of Re 1 per equity share at a price of Rs 191.32…
No USFDA approval for SPARC’s Glaucoma eyedrop
SPARC had sought US FDA approval for Latanoprost BAK-free to sale in the US market
‘Innovation & Excellence’ sweep India Pharma Awards 2014
UBM India recognises leading innovators across nine categories
CPhI & P-MEC India 2014 show begins in Mumbai
Expo likely to be attended by over 30,000 delegates from across the globe
Express Pharma (Vol. 10, No. 3) December 1-15, 2014 Part I
Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994,…
Express Pharma (Vol. 10, No. 3) December 1-15, 2014 Part II
Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994,…
UBM India, Express Pharma organise panel discussion
The panel discussed impediments and opportunities facing Indian pharma as it transitioned form a volumes to a value play
Pfizer concludes merger with Wyeth
Files order with the Registrar of Companies to conclude the merger process